(Q46055303)

English

Optimal dosing of galantamine in patients with mild or moderate Alzheimer's disease: post Hoc analysis of a randomized, double-blind, placebo-controlled trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19358618

Optimal dosing of galantamine in patients with mild or moderate Alzheimer's disease: post Hoc analysis of a randomized, double-blind, placebo-controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19358618

Alzheimer's disease

0 references

1 reference

based on heuristic

inferred from title

author name string

Stephen Aronson

1

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19358618

Bart Van Baelen

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19358618

Shane Kavanagh

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19358618

Susanne Schwalen

4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19358618

publication date

1 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19358618

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19358618

26

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19358618

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19358618

231-239

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19358618

https://scigraph.springernature.com/pub.10.2165/00002512-200926030-00004

0 references

Treatment guidelines for Alzheimer's disease: redefining perceptions in primary care

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200926030-00004

21 January 2018

Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200926030-00004

21 January 2018

A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200926030-00004

21 January 2018

A new rating scale for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200926030-00004

21 January 2018

Alzheimer Disease in the US Population

1 reference

https://pubmed.ncbi.nlm.nih.gov/19358618

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Global prevalence of dementia: a Delphi consensus study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19358618

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19358618

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Galantamine: a randomized, double-blind, dose comparison in patients with Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19358618

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Should the Mini Mental State Examination be used to monitor dementia treatments?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19358618

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Galantamine is an allosterically potentiating ligand of the human alpha4/beta2 nAChR

1 reference

https://pubmed.ncbi.nlm.nih.gov/19358618

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19358618

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical features of Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19358618

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19358618

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholinergic markers in elderly patients with early signs of Alzheimer disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19358618

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measuring cognitive change in a cohort of patients with Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19358618

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19358618

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00002512-200926030-00004

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19358618

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19358618

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46055303&oldid=2089624888"